| Literature DB >> 29130028 |
Eric K Kwong1, Xiaojiaoyang Li1, Phillip B Hylemon1, Huiping Zhou1.
Abstract
The ever-increasing prevalence of metabolic diseases such as dyslipidemia and diabetes in the western world continues to be of great public health concern. Biologically active sphingolipids, such as sphingosine 1-phosphate (S1P) and ceramide, are important regulators of lipid metabolism. S1P not only directly functions as an active intracellular mediator, but also activates multiple signaling pathways via five transmembrane G-protein coupled receptors (GPCRs), S1PR1-5. S1P is exclusively formed by sphingosine kinases (SphKs). Two isoforms of SphKs, SphK1 and SphK2, have been identified. Recent identification of the conjugated bile acid-induced activation of S1PR2 as a key regulator of SphK2 opened new directions for both the sphingolipid and bile acid research fields. The role of SphKs/S1P-mediated signaling pathways in health and various human diseases has been extensively reviewed elsewhere. This review focuses on recent findings related to SphKs/S1P-medaited signaling pathways in regulating hepatic lipid metabolism.Entities:
Keywords: G protein-coupled receptor; Hepatic lipid metabolism; Metabolic diseases; Sphingolipids; Sphingosine 1-phosphate; Sphingosine kinase
Year: 2017 PMID: 29130028 PMCID: PMC5678993 DOI: 10.1007/s40495-017-0093-2
Source DB: PubMed Journal: Curr Pharmacol Rep ISSN: 2198-641X